Marshall Wace, LLP Apollo Endosurgery, Inc. Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.65 - $6.04 $67,535 - $111,758	-18,503 Reduced 23.9%	58,923 $215,000
Q1 2022 May 16, 2022	SELL	$5.01 - $8.77 $136,472 - $238,894	-27,240 Reduced 26.03%	77,426 $468,000
Q4 2021 Feb 14, 2022	SELL	$7.64 - $10.11 $338,879 - $448,439	-44,356 Reduced 29.76%	104,666 $882,000
Q3 2021 Nov 15, 2021	BUY	$7.35 - $9.93 $60,255 - $81,406	8,198 Added 5.82%	149,022 $1.35 Million
Q2 2021 Aug 13, 2021	SELL	$5.37 - $8.95 $1.26 Million - $2.1 Million	-234,475 Reduced 62.48%	140,824 $1.14 Million
Q1 2021 May 17, 2021	BUY	$3.54 - $6.46 $1.33 Million - $2.42 Million	375,299 New	375,299 $2.07 Million

527K

Ticker APEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,686,500
Description
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible en...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.